ATEC
Alphatec Holdings, Inc. Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$7.04Close
$1.1BMarket cap
$6.99 – $22.6852-week range
Late-januaryNext report · estimated
Highlights
Cautions
- Not in an uptrend 0 of 8 trend conditions
- Lagging the market RS 4 · weaker than 96% of stocks over 12 months
- Far from its high 69% below its 52-week high
- Distribution down-day volume 1.9× up-day volume over 50 sessions
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
69%
1wk
down 36.6%
price change
1mo
down 31.8%
price change
12-month return
down 57%
market up 11% ·
its own down 68%
F-score
6 / 9
Mixed
Altman Z
-0.73
Elevated risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
85.1×
price / book
Earnings yield
down 5.9%
EBIT / enterprise value
Cheaper than
12%
of the market · expensive
Revenue growth
up 25%
year on year
EPS growth
—
latest quarter
Sales growth
up 13%
latest quarter · -3 pts
ROE
down 1154%
return on equity
Free cash margin
0%
$2.8M FCF
D/E
40.35
long-term debt / equity
Net debt / EBITDA
—
Interest cover
Lossoperating loss
Piotroski tests
- not yet profitable on its assets
- short-term liquidity weakened
- issued more shares
- generating cash from operations
- profitability improving
- profits backed by cash
- reduced long-term debt
- gross margin widened
- assets working harder
Repair signals
- FCF turned positive ($-128M → $3M)
- Long-term debt down 13% ($0.6B → $0.5B)
Trade setup
ATR%
11.5%
$0.81 a day · 2×ATR $5.42
RS
4 / 99
vs the universe
Trend
0 / 8
trend template
Relative volume
11.5×
vs 50-day average
Up/down volume
0.53
50 sessions
Implied move
—
no scheduled report
Trend template · 0 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
- Losing money before interest is even paid The company made an operating loss, so interest is not covered at all - the debt is being serviced from cash reserves, asset sales or new borrowing rather than from the business.
- Shareholders diluted The share count rose 4.3% over the year, from 144m to 150m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Oct 29, 2026
Last shock
Oct 30, 2026-38% in one session9.4× volumeon results0% since
Financials
- Gross 70%
- Net -19%
- Free cash 0%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $144.9M | $243.2M | $350.9M | $482.3M | $611.6M | $764.2M |
| Gross margin | 71% | 65% | 66% | 64% | 69% | 70% |
| Operating income | -$58.9M | -$128.1M | -$147.0M | -$173.4M | -$136.2M | -$82.1M |
| Net income | -$79.0M | -$143.0M | -$151.3M | -$186.6M | -$162.1M | -$143.4M |
| Net margin | -55% | -59% | -43% | -39% | -27% | -19% |
| Earnings per share | -$1.18 | -$1.49 | -$1.46 | -$1.54 | -$1.13 | -$0.96 |
| Free cash flow | -$69.5M | -$141.9M | -$124.6M | -$159.0M | -$127.9M | $2.8M |
| Free cash margin | -48% | -58% | -36% | -33% | -21% | 0% |
| Cash | $107.8M | $187.2M | $84.7M | $221.0M | $138.8M | $160.8M |
| Long-term debt | $38.0M | $326.5M | $349.5M | $511.0M | $574.5M | $501.4M |
| Shareholders' equity | $129.9M | $80.7M | -$34.7M | $78.1M | -$14.2M | $12.4M |
| Shares outstanding | 82.10m | 99.54m | 106.64m | 139.25m | 144.13m | 150.26m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Oct 29, 2026 | Quarterly ↗ | Sep 30, 2026 | 29d |
| Aug 4, 2026 | Quarterly ↗ | Jun 30, 2026 | 35d |
| May 5, 2026 | Quarterly ↗ | Mar 31, 2026 | 35d |
| Feb 24, 2026 | Annual ↗ | Dec 31, 2025 | 55d |
| Oct 30, 2025 | Quarterly ↗ | Sep 30, 2025 | 30d |
| Jul 31, 2025 | Quarterly ↗ | Jun 30, 2025 | 31d |
| May 1, 2025 | Quarterly ↗ | Mar 31, 2025 | 31d |
| Feb 26, 2025 | Annual ↗ | Dec 31, 2024 | 57d |
| Oct 30, 2024 | Quarterly ↗ | Sep 30, 2024 | 30d |
| Jul 31, 2024 | Quarterly ↗ | Jun 30, 2024 | 31d |
| May 7, 2024 | Quarterly ↗ | Mar 31, 2024 | 37d |
| Feb 27, 2024 | Annual ↗ | Dec 31, 2023 | 58d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 29, 2026 | Results ↗ |
| Aug 4, 2026 | Results ↗ |
| Jun 11, 2026 | Director or officer change · Shareholder vote ↗ |
| May 5, 2026 | Material agreement · Agreement ended · Results · New obligation ↗ |
| Mar 3, 2026 | Director or officer change · Other events ↗ |
| Feb 24, 2026 | Results ↗ |
| Jan 12, 2026 | Results ↗ |
| Nov 7, 2025 | Other events ↗ |
| Oct 30, 2025 | Results ↗ |
| Jul 31, 2025 | Results ↗ |
| Jun 13, 2025 | Charter or bylaws · Shareholder vote ↗ |
| May 1, 2025 | Results ↗ |